Centanafadine extended-release capsules

centanafadine · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Centanafadine extended-release capsules, covering 2023-01-13 to 2023-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD) [Phase 2]

See pricing